Skip to main content

Table 3 Standardised difference of confounding variables between TPV/PR and BOC/PR patients prior to matching

From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

  Mean TPV/PR Mean BOC/PR Standardised difference
Treatment experinced 0.31 0.24 0.154
Presence of cirrhosis 0.29 0.26 0.058
Age 45.73 47.62 −0.174
BMI 26.7 26.73 −0.006
Baseline HCV > 800,000 0.49 0.6 −0.203
GT1 0.19 0.11 0.225
GT1b 0.26 0.33 −0.153
IL28B CT 0.49 0.53 −0.072
IL28B TT 0.17 0.11 0.119